Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: Analysis of a single center

Growth Hormone and IGF Research

Volumn 22, Issue 5, 2012, Pages 180-185

  Bechtold, S ^a   Beyerlein, A ^b   Ripperger, P ^c   Roeb, J ^a   Dalla Pozza, R ^a   Hafner R ^c   Haas, J P ^c   Schmidt, H ^a  

^a University Children's Hospital   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c German Center of pediatric Rheumatology   (Germany)

Author keywords

Final height; Growth disturbance; Growth hormone; Juvenile idiopathic arthritis; Total pubertal growth

Indexed keywords

GROWTH HORMONE;

ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; EARLY INTERVENTION; FEMALE; GROWTH RETARDATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MALE; PUBERTY;

EID: 84865378456     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.07.002     Document Type: Article

References (30)

1. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002, 41:1428-1435.
2. Pass C., MacRae V.E., Ahmed S.F., Farquharson C. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem. Funct. 2009, 27:119-127.
3. Liem J.J., Rosenberg A.M. Growth patterns in juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 2003, 21:663-668.
4. Tynjala P., Lahdenne P., Vahasalo P., Kautiainen H., Honkanen V. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann. Rheum. Dis. 2006, 65:1044-1049.
5. Ranke M.B., Martin D.D., Lindberg A. Prediction model of total pubertal growth in idiopathic growth hormone deficiency: analysis of data from KIGS. Horm. Res. 2003, 60:58-59.
6. Pozo J., Argente J. Delayed puberty in chronic illness. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:73-90.
7. Rusconi R., Appiani A., Dacco V., Ardissino G., Testa S., Carnelli V. Pubertal growth and final height in children with chronic renal failure on conservative treatment. J. Pediatr. Endocrinol. Metab. 2003, 16(Suppl. 2):271-276.
8. Petty R.E. Classification of childhood arthritis: a work in progress. Baillieres Clin. Rheumatol. 1998, 12:181-190.
9. Bechtold S., Ripperger P., Dalla Pozza R., et al. Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study. J. Clin. Endocrinol. Metab. 2007, 92:3013-3018.
10. Miller W. The adrenal cortex 1991, Appelton & Lange, Norwalk, CT.
11. Prader A., Largo R.H., Molinari L., Issler C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv. Paediatr. Acta Suppl. 1989, 52:1-125.
12. Braziuniene I., Wilson T.A., Lane A.H. Accuracy of self-reported height measurements in parents and its effect on mid-parental target height calculation. BMC Endocr. Disord. 2007, 7:2.
13. Greulich W. Radiographic atlas of skeletal development of the hand and wrist 1958, Stanford University Press, Palo Alto.
14. Tanner J.M., Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Child. 1976, 51:170-179.
15. Steinbrocker O., Traeger C.H., Batterman R.C. Therapeutic criteria in rheumatoid arthritis. J. Am. Med. Assoc. 1949, 140:659-662.
16. Iglesias M.J., Cuttica R.J., Herrera Calvo M., Micelotta M., Pringe A., Brusco M.I. Design and validation of a new scale to assess the functional ability in children with juvenile idiopathic arthritis (JIA). Clin. Exp. Rheumatol. 2006, 24:713-718.
17. Simon D., Bechtold S. Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis. Horm. Res. 2009, 72(Suppl. 1):55-59.
18. Simon D. Management of growth retardation in juvenile idiopathic arthritis. Horm. Res. 2007, 68(Suppl. 5):122-125.
19. Solari N., Viola S., Pistorio A., et al. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. Arthritis Rheum. 2008, 59:1571-1579.
20. Ranke M.B., Lindberg A. Predicting growth in response to growth hormone treatment. Growth Horm. IGF Res. 2009, 19:1-11.
21. Ranke M.B., Lindberg A., Chatelain P., et al. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J. Clin. Endocrinol. Metab. 1999, 84:1174-1183.
22. Mehls O., Wuhl E., Tonshoff B., Schaefer F., Nissel R., Haffner D. Growth hormone treatment in short children with chronic kidney disease. Acta Paediatr. 2008, 97:1159-1164.
23. Ranke M.B., Lindberg A. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review. Horm. Res. Paediatr. 2011, 75:423-432.
24. Rosen D.S. Pubertal growth and sexual maturation for adolescents with chronic illness or disability. Pediatrician 1991, 18:105-120.
25. Donaldson M.D. Growth hormone therapy in Turner syndrome-current uncertainties and future strategies. Horm. Res. 1997, 48(Suppl. 5):35-44.
26. Simon D., Prieur A.M., Quartier P., Charles Ruiz J., Czernichow P. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study. J. Clin. Endocrinol. Metab. 2007, 92:2567-2573.
27. Saggese G., Federico G., Barsanti S., Fiore L. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study. J. Clin. Endocrinol. Metab. 2001, 86:1900-1904.
28. Simon D. Puberty in chronically diseased patients. Horm. Res. 2002, 57(Suppl. 2):53-56.
29. Giannini E.H., Ilowite N.T., Lovell D.J., et al. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2010, 62:3259-3264.
30. Gasser T., Kohler W., Muller H.G., Largo R., Molinari L., Prader A. Human height growth: correlational and multivariate structure of velocity and acceleration. Ann. Hum. Biol. 1985, 12:501-515.